<DOC>
	<DOCNO>NCT00940212</DOCNO>
	<brief_summary>The primary aim study investigate safety tolerability AZD2423 single dos healthy volunteer .</brief_summary>
	<brief_title>Study Investigate Safety , Tolerability Pharmacokinetics AZD2423 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Provision sign date , write informed consent prior study specific procedure Have body mass index ( BMI ) ≥18 ≤30 kg/m2 , calculate investigator , weigh least 50 kg 100 kg Healthy male nonfertile female volunteer suitable vein cannulation repeat venipuncture History clinically significant disease disorder , opinion investigator , may either put subject risk participation study , influence result subject 's ability participate study History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug Any clinically significant illness/infection medical/surgical procedure trauma , judge Principal Investigator , within 3 month first administration investigational product</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>healthy</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>